Clinical Trial

Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT).

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 31, 2024 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for the treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-12-31.
Trial Details
NCT Number NCT06202339
Lead Sponsor Alpha Tau Medical LTD.
Conditions Carcinoma of the Vulva, Recurrent Carcinoma of the Vulva
Enrollment 10 participants
Start Date 2024-04
Primary Completion 2026-04 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2024-01-31